BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24159818)

  • 1. [Magnetic dipole interaction of endogenous magnetic nanoparticles with magnetoliposomes for targeted drug delivery].
    Gorobets SV; Gorobets OIu; Chizh IuM; Siveniuk DV
    Biofizika; 2013; 58(3):488-94. PubMed ID: 24159818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controllable release from high-transition temperature magnetoliposomes by low-level magnetic stimulation.
    Spera R; Apollonio F; Liberti M; Paffi A; Merla C; Pinto R; Petralito S
    Colloids Surf B Biointerfaces; 2015 Jul; 131():136-40. PubMed ID: 26042528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model.
    Lueshen E; Venugopal I; Kanikunnel J; Soni T; Alaraj A; Linninger A
    Nanomedicine (Lond); 2014; 9(8):1155-69. PubMed ID: 23862614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents.
    Jabalera Y; Fernández-Vivas A; Iglesias GR; Delgado ÁV; Jimenez-Lopez C
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110435. PubMed ID: 31430636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantum dots conjugated with Fe3O4-filled carbon nanotubes for cancer-targeted imaging and magnetically guided drug delivery.
    Chen ML; He YJ; Chen XW; Wang JH
    Langmuir; 2012 Nov; 28(47):16469-76. PubMed ID: 23131026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microstructure study of liposomes decorated by hydrophobic magnetic nanoparticles.
    Qiu D; An X; Chen Z; Ma X
    Chem Phys Lipids; 2012 Jul; 165(5):563-70. PubMed ID: 22728111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetoliposomes prepared by reverse-phase followed by sequential extrusion: characterization and possibilities in the treatment of inflammation.
    García-Jimeno S; Escribano E; Queralt J; Estelrich J
    Int J Pharm; 2011 Feb; 405(1-2):181-7. PubMed ID: 21129463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release from magnetoliposomes aqueous suspensions exposed to a low intensity magnetic field.
    Spera R; Petralito S; Liberti M; Merla C; d'Inzeo G; Pinto R; Apollonio F
    Bioelectromagnetics; 2014 May; 35(4):309-12. PubMed ID: 24482311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle actuated hollow drug delivery vehicles.
    Amstad E; Reimhult E
    Nanomedicine (Lond); 2012 Jan; 7(1):145-64. PubMed ID: 22191783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.
    Nowicka AM; Kowalczyk A; Jarzebinska A; Donten M; Krysinski P; Stojek Z; Augustin E; Mazerska Z
    Biomacromolecules; 2013 Mar; 14(3):828-33. PubMed ID: 23327587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical application of functionalized magnetic nanoparticles.
    Ito A; Shinkai M; Honda H; Kobayashi T
    J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed magnetic field induced fast drug release from magneto liposomes via ultrasound generation.
    Podaru G; Ogden S; Baxter A; Shrestha T; Ren S; Thapa P; Dani RK; Wang H; Basel MT; Prakash P; Bossmann SH; Chikan V
    J Phys Chem B; 2014 Oct; 118(40):11715-22. PubMed ID: 25110807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer.
    Rodrigues ARO; Mendes PMF; Silva PML; Machado VA; Almeida BG; Araújo JP; Queiroz MRP; Castanheira EMS; Coutinho PJG
    Colloids Surf B Biointerfaces; 2017 Oct; 158():460-468. PubMed ID: 28732311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configurations and control of magnetic fields for manipulating magnetic particles in microfluidic applications: magnet systems and manipulation mechanisms.
    Cao Q; Han X; Li L
    Lab Chip; 2014 Aug; 14(15):2762-77. PubMed ID: 24903572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle impacts reveal magnetic field induced agglomeration and reduced dissolution rates.
    Tschulik K; Compton RG
    Phys Chem Chem Phys; 2014 Jul; 16(27):13909-13. PubMed ID: 24898763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible magnetic liposomes for temperature triggered drug delivery.
    Ding X; Cai K; Luo Z; Li J; Hu Y; Shen X
    Nanoscale; 2012 Oct; 4(20):6289-92. PubMed ID: 22976154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stealth Magnetoliposomes Based on Calcium-Substituted Magnesium Ferrite Nanoparticles for Curcumin Transport and Release.
    Cardoso BD; Rodrigues ARO; Almeida BG; Amorim CO; Amaral VS; Castanheira EMS; Coutinho PJG
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A magnetically controlled MEMS device for drug delivery: design, fabrication, and testing.
    Pirmoradi FN; Jackson JK; Burt HM; Chiao M
    Lab Chip; 2011 Sep; 11(18):3072-80. PubMed ID: 21860883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New forms of superparamagnetic nanoparticles for biomedical applications.
    Xu C; Sun S
    Adv Drug Deliv Rev; 2013 May; 65(5):732-43. PubMed ID: 23123295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in magnetoliposome for heart drug delivery.
    Namdari M; Cheraghi M; Negahdari B; Eatemadi A; Daraee H
    Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-7. PubMed ID: 28272903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.